Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Amgen Safety Net Foundation (ASNF) is a non-profit organization that provides Amgen's portfolio of medicines at no cost to qualifying uninsured or underinsured patients in the United States. As a patient assistance program, it serves as a critical resource for individuals who meet specific income eligibility requirements and lack adequate insurance coverage for their prescribed Amgen treatments. The foundation supports access to therapies across various therapeutic areas, including oncology, cardiovascular disease, inflammation, and bone health. By removing financial barriers, ASNF aims to ensure that patients can adhere to their treatment regimens regardless of their economic status. The foundation is a separate legal entity from Amgen Inc. and operates as a 501(c)(3) organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amgen Safety Net Foundation.